[ad_1]
Dublin, December 15, 2021 (Global News Agency) – “Global Targeted Therapy Market 2021-2026” Report has been added to ResearchAndMarkets.com supply.
The global targeted therapy market will grow from US$100.9 billion in 2021 to US$142.6 billion in 2026, with a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2021 to 2026.
Global market trend analysis, including 2019-2020 data, 2021 estimates, and compound annual growth rate (CAGR) forecasts to 2026
- The global small molecule market will grow from US$60.3 billion in 2021 to US$83.1 billion in 2026, with a compound annual growth rate of 6.6% during the forecast period of 2021-2026.
- The global monoclonal antibody market will grow from US$40.6 billion in 2021 to US$59.5 billion in 2026, with a compound annual growth rate of 8.0% during the forecast period from 2021 to 2026.
Report scope
The scope of this research involves the global targeted therapy market. The report covers the entire market for targeted therapy, which includes two main types, small molecules and monoclonal antibodies. According to the application, targeted therapy is divided into lung cancer, breast cancer, blood cancer, colorectal cancer and so on.
Cancer is the leading cause of death in 2020, and 10 million people worldwide die of cancer. This…
The full story can be found on Benzinga.com
[ad_2]
Source link
